These Analysts Revise Their Forecasts On HCA Healthcare Following Q4 Results

Core Insights - HCA Healthcare Inc. reported better-than-expected earnings for Q4, with revenues of $18.29 billion, a 5.7% year-over-year increase, and adjusted EPS of $6.22, surpassing consensus estimates [1][2] - The company forecasts 2025 EPS between $24.05 and $25.85, with a sales outlook of $72.8 billion to $75.8 billion, indicating continued growth [2][3] Financial Performance - Q4 revenues reached $18.29 billion, exceeding the consensus of $18.23 billion [1] - Adjusted EPS for Q4 was $6.22, up from $5.90 a year ago, surpassing the consensus of $6.13 [1] - For 2025, HCA expects a net profit of $5.85 billion to $6.29 billion and adjusted EBITDA of $14.30 billion to $15.10 billion [3] Future Outlook - Capital expenditures for 2025 are estimated at approximately $5.0 billion to $5.2 billion, excluding acquisitions [3] - Analysts have adjusted their price targets post-earnings, with Barclays lowering its target from $392 to $366 while maintaining an Overweight rating, and Cantor Fitzgerald maintaining a $405 target [3]